FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

David Rimm

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Co-author Network

Publications

TOP 3
Vamsidhar Velcheti; David L Rimm; Kurt A Schalper
Sarcomatoid Lung Carcinomas Show High Levels of Programmed Death Ligand-1 (PD-L1).
Marisa P Dolled-Filhart; David L Rimm
Gene expression array analysis to determine tissue of origin of carcinoma of unknown primary: cutting edge or already obsolete?
Lewis D Hahn; Clifford Hoyt; David L Rimm; Constantine Theoharis
Spatial spectral imaging as an adjunct to the Bethesda classification of thyroid fine-needle aspiration specimens.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of David Rimm (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Vamsidhar Velcheti; David L Rimm; Kurt A Schalper
Sarcomatoid Lung Carcinomas Show High Levels of Programmed Death Ligand-1 (PD-L1).
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2013;8(6):803-5.
2013: Marisa P Dolled-Filhart; David L Rimm
Gene expression array analysis to determine tissue of origin of carcinoma of unknown primary: cutting edge or already obsolete?
Cancer cytopathology 2013;121(3):129-35.
2013: Lewis D Hahn; Clifford Hoyt; David L Rimm; Constantine Theoharis
Spatial spectral imaging as an adjunct to the Bethesda classification of thyroid fine-needle aspiration specimens.
Cancer cytopathology 2013;121(3):162-7.
2013: Allison W Welsh; Hallie Wimberly; Malini Harigopal; Manju Prasad; David L Rimm
Quantitative analysis of estrogen receptor expression shows SP1 antibody is more sensitive than 1D5.
Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry 2013;21(2):139-47.
2013: Vamsidhar Velcheti; Xiaopan Yao; Kurt Schalper; Huan Cheng; Yanhong Deng; Kavita Dhodapkar; Scott Gettinger; Mehmet Kocoglu; David L Rimm
High SOX2 Levels Predict Better Outcome in Non-Small Cell Lung Carcinomas.
PloS one 2013;8(4):e61427.
2012: Veronique M Neumeister; Fabio Parisi; Summar Siddiqui; Maria Vassilakopoulou; Elizabeth R Zarrella; Valsamo Anagnostou; Allison Michal England; David G Hicks; Yuval Kluger; David L Rimm
Quantitative assessment of effect of preanalytic cold ischemic time on protein expression in breast cancer tissues.
Journal of the National Cancer Institute 2012;104(23):1815-24.
2012: Veronique M Neumeister; David L Rimm; Catherine A Sullivan; David P Tuck; Jan Zavada; Kimberley Lezon-Geyda; Jia Li; Robert Lindner; Maritza Martel; Peter M Glazer; Lyndsay Harris
Hypoxia-induced protein CAIX is associated with somatic loss of BRCA1 protein and pathway activity in triple negative breast cancer.
Breast cancer research and treatment 2012;136(1):67-75.
2012: Jason A Hanna; Seema Agarwal; Lewis Hahn; David L Rimm
In situ measurement of miR-205 in malignant melanoma tissue supports its role as a tumor suppressor microRNA.
Laboratory investigation; a journal of technical methods and pathology 2012;92(10):1390-7.
2012: Anastasios Dimou; Veronique Neumeister; Seema Agarwal; Valsamo Anagnostou; Konstantinos SYRIGOS; David L Rimm
Measurement of aldehyde dehydrogenase 1 expression defines a group with better prognosis in patients with non-small cell lung cancer.
The American journal of pathology 2012;181(4):1436-42.
2012: Maria T Baquero; Huan Cheng; Jason A Hanna; Lyndsay N Harris; Annette M Molinaro; Veronique Neumeister; David L Rimm
Stathmin expression and its relationship to microtubule-associated protein tau and outcome in breast cancer.
Cancer 2012;118(19):4660-9.
2012: Jason A Hanna; Salil Kumar; Frank Slack; Hallie Wimberly; Seema Agarwal; David L Rimm
Quantitative analysis of microRNAs in tissue microarrays by in situ hybridization.
BioTechniques 2012;52(4):235-45.
2012: Valsamo K Anagnostou; Gerold Bepler; Daniel Boffa; Taxiarchis Botsis; Frank C Detterbeck; Anastasios T Dimou; Dimitrios Dougenis; Scott N Gettinger; Mark D Gustavson; Robert J Homer; Elizabeth J Killiam; Konstantinos N Syrigos; Lynn T Tanoue; Vassiliki Zolota; David L Rimm
Molecular classification of nonsmall cell lung cancer using a 4-protein quantitative assay.
Cancer 2012;118(6):1607-18.
2012: Seema Agarwal; David L Rimm
Making every cell like HeLa a giant step for cell culture.
The American journal of pathology 2012;180(2):443-5.
2012: Jennifer M Bordeaux; Huan Cheng; Bruce G Haffty; Donald R Lannin; Yuling Luo; Xiao-Jun Ma; Nan Su; Allison W Welsh; Xingyong Wu; David L Rimm
Quantitative in situ measurement of estrogen receptor mRNA predicts response to tamoxifen.
PloS one 2012;7(5):e36559.
2012: Allison W Welsh; Gregory S Young; Lisa Ryden; Rachel Schiff; Mark E Sherman; Jonine D Figueroa; N Lynn Henry; Chungyeul Kim; Donald R Lannin; Richard R Love; David L Rimm
Cytoplasmic estrogen receptor in breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(1):118-26.
2011: David L Rimm
C-path: a Watson-like visit to the pathology lab.
Science translational medicine 2011;3(108):108fs8.
2011: Anees B Chagpar; Robert L Camp; David L Rimm
Lymph node ratio should be considered for incorporation into staging for breast cancer.
Annals of surgical oncology 2011;18(11):3143-8.
2011: Allison W Welsh; Elaine T Alarid; Peter Gershkovich; Bruce G Haffty; Malini Harigopal; Sudha Kumar; Christopher Moeder; David L Rimm
Standardization of estrogen receptor measurement in breast cancer suggests false-negative results are a function of threshold intensity rather than percentage of positive cells.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(22):2978-84.
2011: Yalai Bai; Robert L Camp; Huan Cheng; Arun Gopinath; Eirini Pectasides; David L Rimm; Summar Siddiqui; Juliana Tolles; Annette M Molinaro
Quantitative assessment shows loss of antigenic epitopes as a function of pre-analytic variables.
Laboratory investigation; a journal of technical methods and pathology 2011;91(8):1253-61.
2011: David L Rimm; Torsten O Nielsen; Scott D Jewell; Daniel C Rohrer; Gloria Broadwater; Frederic Waldman; Kisha A Mitchell; Baljit Singh; Gregory J Tsongalis; Wendy L Frankel; anthony magliocco; Jonathan F Lara; Eric D Hsi; Ira J Bleiweiss; Sunil S Badve; Beiyun Chen; Peter M Ravdin; Richard L Schilsky; Ann D Thor; Donald A Berry
Cancer and Leukemia Group B Pathology Committee guidelines for tissue microarray construction representing multicenter prospective clinical trial tissues.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(16):2282-90.
2011: Lucia B Jilaveanu; Christopher R Zito; Saadia A Aziz; Ashok Chakraborty; Michael A Davies; Robert L Camp; David L Rimm; Arkadiusz Dudek; Mario Sznol; Harriet M Kluger
In vitro studies of dasatinib, its targets and predictors of sensitivity.
Pigment cell & melanoma research 2011;24(2):386-9.
2011: Maria T Baquero; Kimberly A Bassi; Robert L Camp; Mark D Gustavson; Lyndsay N Harris; Karen Lostritto; Annette M Molinaro; Franck Appia; David L Rimm
Evaluation of prognostic and predictive value of microtubule associated protein tau in two independent cohorts.
Breast cancer research : BCR 2011;13(5):R85.
2011: Juliana Tolles; David L Rimm; Yalai Bai; Maria Baquero; Lyndsay N Harris; Annette M Molinaro
Optimal tumor sampling for immunostaining of biomarkers in breast carcinoma.
Breast cancer research : BCR 2011;13(3):R51.
2010: Saadia A Aziz; Lucia B Jilaveanu; Christopher Zito; Robert L Camp; David L Rimm; Patricia Conrad; Harriet M Kluger
Vertical targeting of the phosphatidylinositol-3 kinase pathway as a strategy for treating melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(24):6029-39.
2010: Antonio Gualberto; Marisa Dolled-Filhart; Mark Gustavson; Jason Christiansen; Yu-Fen Wang; Mary L Hixon; Jennifer Reynolds; Sandra McDonald; Agnes Ang; David L Rimm; Corey J Langer; Johnetta Blakely; Linda L Garland; Luis G Paz-Ares; Daniel D Karp; Adrian V Lee
Molecular analysis of non-small cell lung cancer identifies subsets with different sensitivity to insulin-like growth factor I receptor inhibition.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(18):4654-65.
2010: Bonnie E Gould Rothberg; David L Rimm
Biomarkers: the useful and the not so useful--an assessment of molecular prognostic markers for cutaneous melanoma.
The Journal of investigative dermatology 2010;130(8):1971-87.
2010: Joshua N VanHouten; Catherine Sullivan; Caroline Bazinet; Tom Ryoo; Robert Camp; David L Rimm; Gina Chung; John J Wysolmerski
PMCA2 regulates apoptosis during mammary gland involution and predicts outcome in breast cancer.
Proceedings of the National Academy of Sciences of the United States of America 2010;107(25):11405-10.
2010: Veronique Neumeister; Seema Agarwal; Jennifer Bordeaux; Robert L Camp; David L Rimm
In situ identification of putative cancer stem cells by multiplexing ALDH1, CD44, and cytokeratin identifies breast cancer patients with poor prognosis.
The American journal of pathology 2010;176(5):2131-8.
2010: Valsamo K Anagnostou; Frank J Lowery; Konstantinos N Syrigos; Philip T Cagle; David L Rimm
Quantitative evaluation of protein expression as a function of tissue microarray core diameter: is a large (1.5 mm) core better than a small (0.6 mm) core?
Archives of pathology & laboratory medicine 2010;134(4):613-9.
2010: Malini Harigopal; William E Barlow; Greg Tedeschi; Peggy L Porter; I-Tien Yeh; Charles Haskell; Robert Livingston; Gabriel N Hortobagyi; George Sledge; Charles Shapiro; James N Ingle; David L Rimm; Daniel F Hayes
Multiplexed assessment of the Southwest Oncology Group-directed Intergroup Breast Cancer Trial S9313 by AQUA shows that both high and low levels of HER2 are associated with poor outcome.
The American journal of pathology 2010;176(4):1639-47.
2010: Janice M Mehnert; Mary M McCarthy; Lucia Jilaveanu; Keith T Flaherty; Saadia Aziz; Robert L Camp; David L Rimm; Harriet M Kluger
Quantitative expression of VEGF, VEGF-R1, VEGF-R2, and VEGF-R3 in melanoma tissue microarrays.
Human pathology 2010;41(3):375-84.
2010: Y Nadler; A M González; Robert L Camp; David L Rimm; Harriet M Kluger; Yuval Kluger
Growth factor receptor-bound protein-7 (Grb7) as a prognostic marker and therapeutic target in breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(3):466-73.
2010: Summar Siddiqui; David L Rimm
Pre-analytic variables and phospho-specific antibodies: the Achilles heel of immunohistochemistry.
Breast cancer research : BCR 2010;12(6):113.
2010: Marisa Dolled-Filhart; Mark Gustavson; Robert L Camp; David L Rimm; John L Tonkinson; Jason Christiansen
Automated analysis of tissue microarrays.
Methods in molecular biology (Clifton, N.J.) 2010;664():151-62.
2010: Valsamo K Anagnostou; Frank J Lowery; Vassiliki Zolota; Vassiliki Tzelepi; Arun Gopinath; Camil Liceaga; Nikolaos Panagopoulos; Konstantina Frangia; Lynn T Tanoue; Daniel Boffa; Scott Gettinger; Frank C Detterbeck; Robert J Homer; Dimitrios Dougenis; David L Rimm; Konstantinos N Syrigos
High expression of BCL-2 predicts favorable outcome in non-small cell lung cancer patients with non squamous histology.
BMC cancer 2010;10():186.
2009: Bonnie E Gould Rothberg; Aaron J Berger; Annette M Molinaro; Antonio Subtil; Michael O Krauthammer; Robert L Camp; William R Bradley; Stephan Ariyan; Harriet M Kluger; David L Rimm
Melanoma prognostic model using tissue microarrays and genetic algorithms.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(34):5772-80.
2009: Lucia B Jilaveanu; Christopher R Zito; Saadia A Aziz; Patricia J Conrad; John C Schmitz; Mario Sznol; Robert L Camp; David L Rimm; Harriet M Kluger
C-Raf is associated with disease progression and cell proliferation in a subset of melanomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(18):5704-13.
2009: Paul Weinberger; Ziwei Yu; Panteleimon Kountourakis; Clarence Sasaki; Bruce G Haffty; Diane Kowalski; Mark A Merkley; David L Rimm; Robert L Camp; Amanda Psyrri
Defining molecular phenotypes of human papillomavirus-associated oropharyngeal squamous cell carcinoma: validation of three-class hypothesis.
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 2009;141(3):382-9.
2009: Valsamo K Anagnostou; Gerold Bepler; Konstantinos N Syrigos; Lynn T Tanoue; Scott Gettinger; Robert J Homer; Daniel Boffa; Frank C Detterbeck; David L Rimm
High expression of mammalian target of rapamycin is associated with better outcome for patients with early stage lung adenocarcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(12):4157-64.
2009: Jennifer Giltnane; Christopher B Moeder; Robert L Camp; David L Rimm
Quantitative multiplexed analysis of ErbB family coexpression for primary breast cancer prognosis in a large retrospective cohort.
Cancer 2009;115(11):2400-9.
2009: Saadia A Aziz; Michael Davies; Elah Pick; Christopher Zito; Lucia Jilaveanu; Robert L Camp; David L Rimm; Yuval Kluger; Harriet M Kluger
Phosphatidylinositol-3-kinase as a therapeutic target in melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(9):3029-36.
2009: Malini Harigopal; Jonas Heymann; Sriparna Ghosh; Valsamo Anagnostou; Robert L Camp; David L Rimm
Estrogen receptor co-activator (AIB1) protein expression by automated quantitative analysis (AQUA) in a breast cancer tissue microarray and association with patient outcome.
Breast cancer research and treatment 2009;115(1):77-85.
2009: Bonnie E Gould Rothberg; Michael B Bracken; David L Rimm
Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis.
Journal of the National Cancer Institute 2009;101(7):452-74.
2009: S Agarwal; Cynthia A Zerillo; J Kolmakova; J G Christensen; Lyndsay N Harris; David L Rimm; Michael P DiGiovanna; David F Stern
Association of constitutively activated hepatocyte growth factor receptor (Met) with resistance to a dual EGFR/Her2 inhibitor in non-small-cell lung cancer cells.
British journal of cancer 2009;100(6):941-9.
2009: Lucia Jilaveanu; Christopher Zito; Sandra J Lee; Katherine L Nathanson; Robert L Camp; David L Rimm; Keith T Flaherty; Harriet M Kluger
Expression of sorafenib targets in melanoma patients treated with carboplatin, paclitaxel and sorafenib.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(3):1076-85.
2009: C A W Sullivan; Sankar Ghosh; Idris Tolgay Ocal; Robert L Camp; David L Rimm; Gina G Chung
Microvessel area using automated image analysis is reproducible and is associated with prognosis in breast cancer.
Human pathology 2009;40(2):156-65.
2009: Valsamo K Anagnostou; Konstantinos SYRIGOS; Gerold Bepler; Robert J Homer; David L Rimm
Thyroid transcription factor 1 is an independent prognostic factor for patients with stage I lung adenocarcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(2):271-8.
2009: Jason A Hanna; Jennifer Bordeaux; David L Rimm; Seema Agarwal
The function, proteolytic processing, and histopathology of Met in cancer.
Advances in cancer research 2009;103():1-23.
2009: Christopher B Moeder; Jennifer Giltnane; Sharon Pozner Moulis; David L Rimm
Quantitative, fluorescence-based in-situ assessment of protein expression.
Methods in molecular biology (Clifton, N.J.) 2009;520():163-75.
2009: John W Emerson; Marisa Dolled-Filhart; Lyndsay Harris; David L Rimm; David Tuck
Quantitative assessment of tissue biomarkers and construction of a model to predict outcome in breast cancer using multiple imputation.
Cancer informatics 2009;7():29-40.
2008: Robert L Camp; Veronique Neumeister; David L Rimm
A decade of tissue microarrays: progress in the discovery and validation of cancer biomarkers.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(34):5630-7.
2008: Sriparna Ghosh; Catherine A W Sullivan; Maciej P Zerkowski; Annette M Molinaro; David L Rimm; Robert L Camp; Gina G Chung
High levels of vascular endothelial growth factor and its receptors (VEGFR-1, VEGFR-2, neuropilin-1) are associated with worse outcome in breast cancer.
Human pathology 2008;39(12):1835-43.
2008: Mark D Gustavson; Annette M Molinaro; Greg Tedeschi; Robert L Camp; David L Rimm
AQUA analysis of thymidylate synthase reveals localization to be a key prognostic biomarker in 2 large cohorts of colorectal carcinoma.
Archives of pathology & laboratory medicine 2008;132(11):1746-52.
2008: Jennifer Giltnane; Annette M Molinaro; Huan Cheng; Andrew Robinson; Dmitry Turbin; Karen Gelmon; David Huntsman; David L Rimm
Comparison of quantitative immunofluorescence with conventional methods for HER2/neu testing with respect to response to trastuzumab therapy in metastatic breast cancer.
Archives of pathology & laboratory medicine 2008;132(10):1635-47.
2008: Bonnie E Gould Rothberg; Christopher B Moeder; Harriet M Kluger; Ruth Halaban; David E Elder; George F Murphy; Alexander Lazar; Victor Prieto; Lynn McDivitt Duncan; David L Rimm
Nuclear to non-nuclear Pmel17/gp100 expression (HMB45 staining) as a discriminator between benign and malignant melanocytic lesions.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2008;21(9):1121-9.
2008: Yasmine Nadler; Robert L Camp; Candice Schwartz; David L Rimm; Harriet M Kluger; Yuval Kluger
Expression of Aurora A (but not Aurora B) is predictive of survival in breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(14):4455-62.
2008: Gretchen M Kreizenbeck; Aaron J Berger; Antonio Subtil; David L Rimm; Bonnie E Gould Rothberg
Prognostic significance of cadherin-based adhesion molecules in cutaneous malignant melanoma.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008;17(4):949-58.
2008: Mary M McCarthy; Elah Pick; Yuval Kluger; B Gould-Rothberg; Rossitza Lazova; Robert L Camp; David L Rimm; Harriet M Kluger
HSP90 as a marker of progression in melanoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(3):590-4.
2008: Ibrahim Mansoor; Carola Zalles; Farhan Zahid; Kirk Gossage; Richard Levenson; David L Rimm
Fine-needle aspiration of follicular adenoma versus parathyroid adenoma: the utility of multispectral imaging in differentiating lesions with subtle cytomorphologic differences.
Cancer 2008;114(1):22-6.
2008: Yasmine Nadler; Robert L Camp; Jennifer Giltnane; Christopher Moeder; David L Rimm; Harriet M Kluger; Yuval Kluger
Expression patterns and prognostic value of Bag-1 and Bcl-2 in breast cancer.
Breast cancer research : BCR 2008;10(2):R35.
2007: Christopher Moeder; Jennifer Giltnane; Malini Harigopal; Annette M Molinaro; Andrew Robinson; Karen Gelmon; David Huntsman; Robert L Camp; David L Rimm
Quantitative justification of the change from 10% to 30% for human epidermal growth factor receptor 2 scoring in the American Society of Clinical Oncology/College of American Pathologists guidelines: tumor heterogeneity in breast cancer and its implications for tissue microarray based assessment of outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(34):5418-25.
2007: Xiaohong Rose Yang; Ruth M Pfeiffer; Montserrat Garcia-Closas; David L Rimm; Jolanta Lissowska; Louise A Brinton; Beata Peplonska; Stephen M Hewitt; Richard W Cartun; Daniza Mandich; Hironobu Sasano; Dean B Evans; Thomas R Sutter; Mark E Sherman
Hormonal markers in breast cancer: coexpression, relationship with pathologic characteristics, and risk factor associations in a population-based study.
Cancer research 2007;67(21):10608-17.
2007: Tamara Handerson; Aaron Berger; Malini Harigopol; David L Rimm; Chikako Nishigori; Masato Ueda; Eiji Miyoshi; Naoyuki Taniguchi; John Pawelek
Melanophages reside in hypermelanotic, aberrantly glycosylated tumor areas and predict improved outcome in primary cutaneous malignant melanoma.
Journal of cutaneous pathology 2007;34(9):679-86.
2007: Mark E Sherman; David L Rimm; Xiaohong Rose Yang; Nilanjan Chatterjee; Louise A Brinton; Jolanta Lissowska; Beata Peplonska; Neonila Szeszenia-Dabrowska; Witold Zatonski; Richard W Cartun; Daniza Mandich; Grzegorz Rymkiewicz; Marcin Ligaj; Stanislaw Lukaszek; Radzislaw Kordek; Zeynep Kalaylioglu; Malini Harigopal; Lori Charrette; Roni T Falk; Douglas Richesson; William F Anderson; Stephen M Hewitt; Montserrat García-Closas
Variation in breast cancer hormone receptor and HER2 levels by etiologic factors: a population-based analysis.
International journal of cancer. Journal international du cancer 2007;121(5):1079-85.
2007: Jennifer Giltnane; Lisa Rydén; Melissa Cregger; Pär-Ola Bendahl; Karin Jirström; David L Rimm
Quantitative measurement of epidermal growth factor receptor is a negative predictive factor for tamoxifen response in hormone receptor positive premenopausal breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(21):3007-14.
2007: Gina G Chung; Maciej P Zerkowski; Sriparna Ghosh; Robert L Camp; David L Rimm
Quantitative analysis of estrogen receptor heterogeneity in breast cancer.
Laboratory investigation; a journal of technical methods and pathology 2007;87(7):662-9.
2007: David L Rimm; Jennifer Giltnane; Christopher Moeder; Malini Harigopal; Gina G Chung; Robert L Camp; Barbara Burtness
Bimodal population or pathologist artifact?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(17):2487-8.
2007: Elah Pick; Yuval Kluger; Jennifer Giltnane; Christopher Moeder; Robert L Camp; David L Rimm; Harriet M Kluger
High HSP90 expression is associated with decreased survival in breast cancer.
Cancer research 2007;67(7):2932-7.
2007: Galina Reshetnikova; Sergei Troyanovsky; David L Rimm
Definition of a direct extracellular interaction between Met and E-cadherin.
Cell biology international 2007;31(4):366-73.
2007: Ziwei Yu; Paul Weinberger; Clarence Sasaki; Brian L Egleston; William F Speier; Bruce G Haffty; Diane Kowalski; Robert L Camp; David L Rimm; Eleftherios Vairaktaris; Barbara Burtness; Amanda Psyrri
Phosphorylation of Akt (Ser473) predicts poor clinical outcome in oropharyngeal squamous cell cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(3):553-8.
2007: Xiaohong Rose Yang; Mark E Sherman; David L Rimm; Jolanta Lissowska; Louise A Brinton; Beata Peplonska; Stephen M Hewitt; William F Anderson; Neonila Szeszenia-Dabrowska; Alicja Bardin-Mikolajczak; Witold Zatonski; Richard W Cartun; Daniza Mandich; Grzegorz Rymkiewicz; Marcin Ligaj; Stanislaw Lukaszek; Radzislaw Kordek; Montserrat García-Closas
Differences in risk factors for breast cancer molecular subtypes in a population-based study.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(3):439-43.
2007: Sharon Pozner-Moulis; Melissa Cregger; Robert L Camp; David L Rimm
Antibody validation by quantitative analysis of protein expression using expression of Met in breast cancer as a model.
Laboratory investigation; a journal of technical methods and pathology 2007;87(3):251-60.
2007: Janiel M Shields; Nancy E Thomas; Melissa Cregger; Aaron J Berger; Michael Leslie; Chad Torrice; Honglin Hao; Shannon Penland; Jack Arbiser; Glynis Scott; Tong Zhou; Menashe Bar-Eli; James E Bear; Channing J Der; William K Kaufmann; David L Rimm; Norman E Sharpless
Lack of extracellular signal-regulated kinase mitogen-activated protein kinase signaling shows a new type of melanoma.
Cancer research 2007;67(4):1502-12.
2007: Maciej P Zerkowski; Robert L Camp; Barbara Burtness; David L Rimm; Gina G Chung
Quantitative analysis of breast cancer tissue microarrays shows high cox-2 expression is associated with poor outcome.
Cancer investigation 2007;25(1):19-26.
2007: Harriet M Kluger; Mary M McCarthy; Ayesha B Alvero; Mario Sznol; Stephan Ariyan; Robert L Camp; David L Rimm; Gil Mor
The X-linked inhibitor of apoptosis protein (XIAP) is up-regulated in metastatic melanoma, and XIAP cleavage by Phenoxodiol is associated with Carboplatin sensitization.
Journal of translational medicine 2007;5():6.
2006: Aristotelis Bamias; Ziwei Yu; Paul Weinberger; Sonia Markakis; Diane Kowalski; Robert L Camp; David L Rimm; Meletios A Dimopoulos; Amanda Psyrri
Automated quantitative analysis of DCC tumor suppressor protein in ovarian cancer tissue microarray shows association with beta-catenin levels and outcome in patients with epithelial ovarian cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(12):1797-802.
2006: Marisa Dolled-Filhart; Lisa Rydén; Melissa Cregger; Karin Jirström; Malini Harigopal; Robert L Camp; David L Rimm
Classification of breast cancer using genetic algorithms and tissue microarrays.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(21):6459-68.
2006: Xiaohong Rose Yang; Lori A Charette; Montserrat Garcia-Closas; Jolanta Lissowska; Edina Paal; Mary Sidawy; Stephen M Hewitt; David L Rimm; Mark E Sherman
Construction and validation of tissue microarrays of ductal carcinoma in situ and terminal duct lobular units associated with invasive breast carcinoma.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 2006;15(3):157-61.
2006: Sharon Pozner-Moulis; Derek J Pappas; David L Rimm
Met, the hepatocyte growth factor receptor, localizes to the nucleus in cells at low density.
Cancer research 2006;66(16):7976-82.
2006: David L Rimm
What brown cannot do for you.
Nature biotechnology 2006;24(8):914-6.
2006: Jennifer Giltnane; John R Murren; David L Rimm; Bonnie L King
AQUA and FISH analysis of HER-2/neu expression and amplification in a small cell lung carcinoma tissue microarray.
Histopathology 2006;49(2):161-9.
2006: Melissa Cregger; Aaron J Berger; David L Rimm
Immunohistochemistry and quantitative analysis of protein expression.
Archives of pathology & laboratory medicine 2006;130(7):1026-30.
2006: Mary M McCarthy; Kyle A DiVito; Mario Sznol; Daniela Kovacs; Ruth Halaban; Aaron J Berger; Keith T Flaherty; Robert L Camp; Rossitza Lazova; David L Rimm; Harriet M Kluger
Expression of tumor necrosis factor--related apoptosis-inducing ligand receptors 1 and 2 in melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(12):3856-63.
2006: Amanda Psyrri; Ziwei Yu; Aristotelis Bamias; Paul Weinberger; Sonia Markakis; Diane Kowalski; Robert L Camp; David L Rimm; Meletios A Dimopoulos
Evaluation of the prognostic value of cellular inhibitor of apoptosis protein in epithelial ovarian cancer using automated quantitative protein analysis.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(6):1179-83.
2006: James D Cowan; David L Rimm; David Tuck
Cruella: developing a scalable tissue microarray data management system.
Archives of pathology & laboratory medicine 2006;130(6):817-22.
2006: Marisa Dolled-Filhart; Anthony McCabe; Jennifer Giltnane; Melissa Cregger; Robert L Camp; David L Rimm
Quantitative in situ analysis of beta-catenin expression in breast cancer shows decreased expression is associated with poor outcome.
Cancer research 2006;66(10):5487-94.
2006: Derek J Pappas; David L Rimm
Direct interaction of the C-terminal domain of alpha-catenin and F-actin is necessary for stabilized cell-cell adhesion.
Cell communication & adhesion 2006;13(3):151-70.
2006: Mohiedean Ghofrani; Danita Beckman; David L Rimm
The value of onsite adequacy assessment of thyroid fine-needle aspirations is a function of operator experience.
Cancer 2006;108(2):110-3.
2006: Gina G Chung; Harry H Yoon; Maciej P Zerkowski; Sriparna Ghosh; Laurie Thomas; Malini Harigopal; Lori A Charette; Ronald R Salem; Robert L Camp; David L Rimm; Barbara Burtness
Vascular endothelial growth factor, FLT-1, and FLK-1 analysis in a pancreatic cancer tissue microarray.
Cancer 2006;106(8):1677-84.
2006: Paul Weinberger; Ziwei Yu; Bruce G Haffty; Diane Kowalski; Malini Harigopal; Janet L Brandsma; Clarence Sasaki; John K Joe; Robert L Camp; David L Rimm; Amanda Psyrri
Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(5):736-47.
2006: Joshua N VanHouten; Namyi Yu; David L Rimm; Jorge Dotto; Andrew Arnold; John J Wysolmerski; Robert Udelsman
Hypercalcemia of malignancy due to ectopic transactivation of the parathyroid hormone gene.
The Journal of clinical endocrinology and metabolism 2006;91(2):580-3.
2005: Anthony McCabe; Marisa Dolled-Filhart; Robert L Camp; David L Rimm
Automated quantitative analysis (AQUA) of in situ protein expression, antibody concentration, and prognosis.
Journal of the National Cancer Institute 2005;97(24):1808-15.
2005: Amanda Psyrri; Mohamad Kassar; Ziwei Yu; Aristotelis Bamias; Paul Weinberger; Sonia Markakis; Diane Kowalski; Robert L Camp; David L Rimm; Meletios A Dimopoulos
Effect of epidermal growth factor receptor expression level on survival in patients with epithelial ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(24 Pt 1):8637-43.
2005: Amanda Psyrri; Aristotelis Bamias; Ziwei Yu; Paul Weinberger; Mohamad Kassar; Sonia Markakis; Diane Kowalski; Eleni Efstathiou; Robert L Camp; David L Rimm; Meletios A Dimopoulos
Subcellular localization and protein levels of cyclin-dependent kinase inhibitor p27 independently predict for survival in epithelial ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(23):8384-90.
2005: Aaron J Berger; Darren W Davis; Carmen Tellez; Victor G Prieto; jeffrey gershenwald; Marcella M Johnson; David L Rimm; Menashe Bar-Eli
Automated quantitative analysis of activator protein-2alpha subcellular expression in melanoma tissue microarrays correlates with survival prediction.
Cancer research 2005;65(23):11185-92.
2005: Cesar Angeletti; Neal R Harvey; Vitali Khomitch; Andrew H Fischer; Richard Levenson; David L Rimm
Detection of malignancy in cytology specimens using spectral-spatial analysis.
Laboratory investigation; a journal of technical methods and pathology 2005;85(12):1555-64.
2005: Summar F Siddiqui; John Pawelek; Tamara Handerson; Chen-Yong Lin; Robert B Dickson; David L Rimm; Robert L Camp
Coexpression of beta1,6-N-acetylglucosaminyltransferase V glycoprotein substrates defines aggressive breast cancers with poor outcome.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(11 Pt 1):2517-23.
2005: Doo Ho Choi; Sung Kim; David L Rimm; Darryl L Carter; Bruce G Haffty
Immunohistochemical biomarkers in patients with early-onset breast carcinoma by tissue microarray.
Cancer journal (Sudbury, Mass.) 2005;11(5):404-11.
2005: Robert C Bast; Hans Lilja; Nicole Urban; David L Rimm; Herbert A Fritsche; Joe Gray; Robert W Veltri; George Klee; Andrew Allen; Nam Kim; Steven Gutman; Mark A Rubin; Andrew Hruszkewycz
Translational crossroads for biomarkers.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(17):6103-8.
2005: Amanda Psyrri; Ziwei Yu; Paul Weinberger; Clarence Sasaki; Bruce G Haffty; Robert L Camp; David L Rimm; Barbara Burtness
Quantitative determination of nuclear and cytoplasmic epidermal growth factor receptor expression in oropharyngeal squamous cell cancer by using automated quantitative analysis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(16):5856-62.
2005: Mary M McCarthy; Mario Sznol; Kyle A DiVito; Robert L Camp; David L Rimm; Harriet M Kluger
Evaluating the expression and prognostic value of TRAIL-R1 and TRAIL-R2 in breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(14):5188-94.
2005: Harriet M Kluger; Dina Chelouche Lev; Yuval Kluger; Mary M McCarthy; Galina Kiriakova; Robert L Camp; David L Rimm; Janet E Price
Using a xenograft model of human breast cancer metastasis to find genes associated with clinically aggressive disease.
Cancer research 2005;65(13):5578-87.
2005: Malini Harigopal; Aaron J Berger; Robert L Camp; David L Rimm; Harriet M Kluger
Automated quantitative analysis of E-cadherin expression in lymph node metastases is predictive of survival in invasive ductal breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(11):4083-9.
2005: Oluwole Fadare; M Rajan Mariappan; Denise Hileeto; Sa Wang; Jessica N McAlpine; David L Rimm
Upstaging based solely on positive peritoneal washing does not affect outcome in endometrial cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2005;18(5):673-80.
2005: Tamara Handerson; Robert L Camp; Malini Harigopal; David L Rimm; John Pawelek
Beta1,6-branched oligosaccharides are increased in lymph node metastases and predict poor outcome in breast carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(8):2969-73.
2005: Elayne Provost; Anthony McCabe; Jessica Stern; Isabel Lizardi; Thomas G D'Aquila; David L Rimm
Functional correlates of mutation of the Asp32 and Gly34 residues of beta-catenin.
Oncogene 2005;24(16):2667-76.
2005: Ziwei Yu; Paul Weinberger; Elayne Provost; Bruce G Haffty; Clarence Sasaki; John K Joe; Robert L Camp; David L Rimm; Amanda Psyrri
beta-Catenin functions mainly as an adhesion molecule in patients with squamous cell cancer of the head and neck.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(7):2471-7.
2005: Ziwei Yu; Paul Weinberger; Bruce G Haffty; Clarence Sasaki; Cynthia Zerillo; John K Joe; Diane Kowalski; James Dziura; Robert L Camp; David L Rimm; Amanda Psyrri
Cyclin d1 is a valuable prognostic marker in oropharyngeal squamous cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(3):1160-6.
2005: Susan A Higgins; Ellen T Matloff; David L Rimm; James Dziura; Bruce G Haffty; Bonnie L King
Patterns of reduced nipple aspirate fluid production and ductal lavage cellularity in women at high risk for breast cancer.
Breast cancer research : BCR 2005;7(6):R1017-22.
2004: Jennifer Giltnane; David L Rimm
Technology insight: Identification of biomarkers with tissue microarray technology.
Nature clinical practice. Oncology 2004;1(2):104-11.
2004: Kyle A DiVito; Aaron J Berger; Robert L Camp; Marisa Dolled-Filhart; David L Rimm; Harriet M Kluger
Automated quantitative analysis of tissue microarrays reveals an association between high Bcl-2 expression and improved outcome in melanoma.
Cancer research 2004;64(23):8773-7.
2004: Aaron J Berger; Robert L Camp; Kyle A DiVito; Harriet M Kluger; Ruth Halaban; David L Rimm
Automated quantitative analysis of HDM2 expression in malignant melanoma shows association with early-stage disease and improved outcome.
Cancer research 2004;64(23):8767-72.
2004: Robert L Camp; Marisa Dolled-Filhart; David L Rimm
X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(21):7252-9.
2004: Paul Weinberger; Ziwei Yu; Bruce G Haffty; Diane Kowalski; Malini Harigopal; Clarence Sasaki; David L Rimm; Amanda Psyrri
Prognostic significance of p16 protein levels in oropharyngeal squamous cell cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(17):5684-91.
2004: Keith Hoek; David L Rimm; Kenneth R Williams; Hongyu Zhao; Stephan Ariyan; Aiping Lin; Harriet M Kluger; Aaron J Berger; Elaine Cheng; Eduardo S. Trombetta; Terence Wu; Michio Niinobe; Kazuaki Yoshikawa; Gregory E Hannigan; Ruth Halaban
Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas.
Cancer research 2004;64(15):5270-82.
2004: Kyle A DiVito; Lori A Charette; David L Rimm; Robert L Camp
Long-term preservation of antigenicity on tissue microarrays.
Laboratory investigation; a journal of technical methods and pathology 2004;84(8):1071-8.
2004: Cesar Angeletti; Vitali Khomitch; Ruth Halaban; David L Rimm
Novel tyramide-based tyrosinase assay for the detection of melanoma cells in cytological preparations.
Diagnostic cytopathology 2004;31(1):33-7.
2004: Rajesh Jaganath; Cesar Angeletti; Richard Levenson; David L Rimm
Diagnostic classification of urothelial cells in urine cytology specimens using exclusively spectral information.
Cancer 2004;102(3):186-91.
2004: Oluwole Fadare; M Rajan Mariappan; Sa Wang; Denise Hileeto; Jessica N McAlpine; David L Rimm
The histologic subtype of ovarian tumors affects the detection rate by pelvic washings.
Cancer 2004;102(3):150-6.
2004: Dina Chelouche Lev; Harriet M Kluger; Aaron J Berger; David L Rimm; Janet E Price
alphaB-crystallin as a marker of lymph node involvement in breast carcinoma.
Cancer 2004;100(12):2543-8.
2004: Harriet M Kluger; Kyle A DiVito; Aaron J Berger; Ruth Halaban; Stephan Ariyan; Robert L Camp; David L Rimm
Her2/neu is not a commonly expressed therapeutic target in melanoma -- a large cohort tissue microarray study.
Melanoma research 2004;14(3):207-10.
2004: Gina G Chung; Maciej P Zerkowski; Idris Tolgay Ocal; Marisa Dolled-Filhart; Jung Y Kang; Amanda Psyrri; Robert L Camp; David L Rimm
beta-Catenin and p53 analyses of a breast carcinoma tissue microarray.
Cancer 2004;100(10):2084-92.
2004: Mark A Rubin; Maciej P Zerkowski; Robert L Camp; Rainer Kuefer; Matthias D Hofer; Arul M Chinnaiyan; David L Rimm
Quantitative determination of expression of the prostate cancer protein alpha-methylacyl-CoA racemase using automated quantitative analysis (AQUA): a novel paradigm for automated and continuous biomarker measurements.
The American journal of pathology 2004;164(3):831-40.
2004: Bruce G Haffty; Analene Hauser; Doo Ho Choi; Nicole Parisot; David L Rimm; Bonnie King; Darryl L Carter
Molecular markers for prognosis after isolated postmastectomy chest wall recurrence.
Cancer 2004;100(2):252-63.
2004: Harriet M Kluger; Marisa Dolled-Filhart; Sofya Rodov; Barry M Kacinski; Robert L Camp; David L Rimm
Macrophage colony-stimulating factor-1 receptor expression is associated with poor outcome in breast cancer by large cohort tissue microarray analysis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(1 Pt 1):173-7.
2003: Aaron J Berger; Harriet M Kluger; Ning Li; Eric Kielhorn; Ruth Halaban; Ze'ev Ronai; David L Rimm
Subcellular localization of activating transcription factor 2 in melanoma specimens predicts patient survival.
Cancer research 2003;63(23):8103-7.
2003: Elayne Provost; Yumi Yamamoto; Isabel Lizardi; Jessica Stern; Thomas G D'Aquila; Richard B Gaynor; David L Rimm
Functional correlates of mutations in beta-catenin exon 3 phosphorylation sites.
The Journal of biological chemistry 2003;278(34):31781-9.
2003: Sung Kim; David L Rimm; Darryl L Carter; Atif Khan; Nicole Parisot; Mayra Alvarez Franco; Allen E Bale; Bruce G Haffty
BRCA status, molecular markers, and clinical variables in early, conservatively managed breast cancer.
The breast journal 2003;9(3):167-74.
2003: Idris Tolgay Ocal; Marisa Dolled-Filhart; Thomas G D'Aquila; Robert L Camp; David L Rimm
Tissue microarray-based studies of patients with lymph node negative breast carcinoma show that met expression is associated with worse outcome but is not correlated with epidermal growth factor family receptors.
Cancer 2003;97(8):1841-8.
2003: Bonnie L King; Steven C Tsai; Michele E Gryga; Thomas G D'Aquila; Steven A Seelig; Larry E Morrison; Kris K B Jacobson; Mona S Legator; David C Ward; David L Rimm; Rogsbert F Phillips
Detection of chromosomal instability in paired breast surgery and ductal lavage specimens by interphase fluorescence in situ hybridization.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(4):1509-16.
2003: Robert L Camp; Marisa Dolled-Filhart; Bonnie L King; David L Rimm
Quantitative analysis of breast cancer tissue microarrays shows that both high and normal levels of HER2 expression are associated with poor outcome.
Cancer research 2003;63(7):1445-8.
2003: Jung Y Kang; Marisa Dolled-Filhart; Idris Tolgay Ocal; Baljit Singh; Chen-Yong Lin; Robert B Dickson; David L Rimm; Robert L Camp
Tissue microarray analysis of hepatocyte growth factor/Met pathway components reveals a role for Met, matriptase, and hepatocyte growth factor activator inhibitor 1 in the progression of node-negative breast cancer.
Cancer research 2003;63(5):1101-5.
2003: Eric Kielhorn; Elayne Provost; Drew Olsen; Thomas G D'Aquila; Bradley L Smith; Robert L Camp; David L Rimm
Tissue microarray-based analysis shows phospho-beta-catenin expression in malignant melanoma is associated with poor outcome.
International journal of cancer. Journal international du cancer 2003;103(5):652-6.
2003: Marisa Dolled-Filhart; Robert L Camp; Diane Kowalski; Bradley L Smith; David L Rimm
Tissue microarray analysis of signal transducers and activators of transcription 3 (Stat3) and phospho-Stat3 (Tyr705) in node-negative breast cancer shows nuclear localization is associated with a better prognosis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(2):594-600.
2002: Robert L Camp; Gina G Chung; David L Rimm
Automated subcellular localization and quantification of protein expression in tissue microarrays.
Nature medicine 2002;8(11):1323-7.
2002: Linda M Ernst; David L Rimm
Quantitative examination of mechanophysical tumor cell enrichment in fine-needle aspiration specimens.
Cancer 2002;96(5):275-9.
2002: Deborah A Dillon; Emanuel Hipolito; Karl Zheng; David L Rimm; José C Costa
p53 mutations as tumor markers in fine needle aspirates of palpable breast masses.
Acta cytologica 2002;46(5):841-7.
2002: Bonnie L King; Giovanna M Crisi; Steven C Tsai; Bruce G Haffty; Rogsbert F Phillips; David L Rimm
Immunocytochemical analysis of breast cells obtained by ductal lavage.
Cancer 2002;96(4):244-9.
2002: Gina G Chung; Eric Kielhorn; David L Rimm
Subjective differences in outcome are seen as a function of the immunohistochemical method used on a colorectal cancer tissue microarray.
Clinical colorectal cancer 2002;1(4):237-42.
2002: Eric Kielhorn; Kevin Schofield; David L Rimm
Use of magnetic enrichment for detection of carcinoma cells in fluid specimens.
Cancer 2002;94(1):205-11.
2001: Gina G Chung; Elayne Provost; Eric Kielhorn; Lori A Charette; Bradley L Smith; David L Rimm
Tissue microarray analysis of beta-catenin in colorectal cancer shows nuclear phospho-beta-catenin is associated with a better prognosis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(12):4013-20.
2001: T Chen; W Yan; Rebecca G Wells; David L Rimm; Jennifer M McNiff; David J Leffell; Michael Reiss
Novel inactivating mutations of transforming growth factor-beta type I receptor gene in head-and-neck cancer metastases.
International journal of cancer. Journal international du cancer 2001;93(5):653-61.
2001: David L Rimm; Robert L Camp; Lori A Charette; D A Olsen; Elayne Provost
Amplification of tissue by construction of tissue microarrays.
Experimental and molecular pathology 2001;70(3):255-64.
2001: Ginesa Garcia-Rostan; Robert L Camp; Agustin Herrero; Maria Luisa Carcangiu; David L Rimm; Giovanni Tallini
Beta-catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis.
The American journal of pathology 2001;158(3):987-96.
2001: Deepti Pradhan; C R Lombardo; S Roe; David L Rimm; Jon S Morrow
alpha -Catenin binds directly to spectrin and facilitates spectrin-membrane assembly in vivo.
The Journal of biological chemistry 2001;276(6):4175-81.
2001: Miguel Reyes-Múgica; Jeffrey A Meyerhardt; J Rzasa; David L Rimm; K R Johnson; M J Wheelock; Michael A Reale
Truncated DCC reduces N-cadherin/catenin expression and calcium-dependent cell adhesion in neuroblastoma cells.
Laboratory investigation; a journal of technical methods and pathology 2001;81(2):201-10.
2001: K Flynn; David L Rimm
Diagnosis of "ASCUS" in women over age 50 is less likely to be associated with dysplasia.
Diagnostic cytopathology 2001;24(2):132-6.
2001: David L Rimm; Robert L Camp; Lori A Charette; J Costa; D A Olsen; M Reiss
Tissue microarray: a new technology for amplification of tissue resources.
Cancer journal (Sudbury, Mass.) 2001;7(1):24-31.
2000: Robert L Camp; Lori A Charette; David L Rimm
Validation of tissue microarray technology in breast carcinoma.
Laboratory investigation; a journal of technical methods and pathology 2000;80(12):1943-9.
2000: Deborah A Dillon; C C Johnson; Mark D Topazian; G Tallini; David L Rimm; J C Costa
The utility of Ki-ras mutation analysis in the cytologic diagnosis of pancreatobiliary neoplasma.
Cancer journal (Sudbury, Mass.) 2000;6(5):294-301.
2000: Kevin Schofield; Thomas G D'Aquila; David L Rimm
E-cadherin expression is a sensitive and specific method for detection of carcinoma cells in fluid specimens.
Diagnostic cytopathology 2000;22(5):263-7.
2000: David L Rimm
Molecular biology in cytopathology: current applications and future directions.
Cancer 2000;90(1):1-9.
2000: Robert L Camp; EB Rimm; David L Rimm
A high number of tumor free axillary lymph nodes from patients with lymph node negative breast carcinoma is associated with poor outcome.
Cancer 2000;88(1):108-13.
1999: Robert L Camp; EB Rimm; David L Rimm
Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma.
Cancer 1999;86(11):2259-65.
1999: Elayne Provost; David L Rimm
Controversies at the cytoplasmic face of the cadherin-based adhesion complex.
Current opinion in cell biology 1999;11(5):567-72.
1999: Ginesa Garcia-Rostan; Giovanni Tallini; Agustin Herrero; Thomas G D'Aquila; Maria Luisa Carcangiu; David L Rimm
Frequent mutation and nuclear localization of beta-catenin in anaplastic thyroid carcinoma.
Cancer research 1999;59(8):1811-5.
1999: David L Rimm; Karel Caca; G Hu; F B Harrison; Eric R Fearon
Frequent nuclear/cytoplasmic localization of beta-catenin without exon 3 mutations in malignant melanoma.
The American journal of pathology 1999;154(2):325-9.
1998: Jason S Gold; A B Reynolds; David L Rimm
Loss of p120ctn in human colorectal cancer predicts metastasis and poor survival.
Cancer letters 1998;132(1-2):193-201.
1998: J L Magda; B A Minger; David L Rimm
Polymerase chain reaction-based detection of clonality as a non-morphologic diagnostic tool for fine-needle aspiration of the breast.
Cancer 1998;84(4):262-7.
1998: S Roe; E R Koslov; David L Rimm
A mutation in alpha-catenin disrupts adhesion in clone A cells without perturbing its actin and beta-catenin binding activity.
Cell adhesion and communication 1998;5(4):283-96.
1998: RA Ghoussoub; Deborah Dillon; Thomas G D'Aquila; EB Rimm; Eric R Fearon; David L Rimm
Expression of c-met is a strong independent prognostic factor in breast carcinoma.
Cancer 1998;82(8):1513-20.
1998: Deborah Dillon; Thomas G D'Aquila; A B Reynolds; Eric R Fearon; David L Rimm
The expression of p120ctn protein in breast cancer is independent of alpha- and beta-catenin and E-cadherin.
The American journal of pathology 1998;152(1):75-82.
1997: Jason S Gold; L Bao; RA Ghoussoub; B R Zetter; David L Rimm
Localization and quantitation of expression of the cell motility-related protein thymosin beta15 in human breast tissue.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1997;10(11):1106-12.
1997: Kevin Schofield; Thomas G D'Aquila; David L Rimm
The cell adhesion molecule, E-cadherin, distinguishes mesothelial cells from carcinoma cells in fluids.
Cancer 1997;81(5):293-8.
1997: E R Koslov; P Maupin; Deepti Pradhan; Jon S Morrow; David L Rimm
Alpha-catenin can form asymmetric homodimeric complexes and/or heterodimeric complexes with beta-catenin.
The Journal of biological chemistry 1997;272(43):27301-6.
1997: RA Ghoussoub; David L Rimm
Degree of dysplasia following diagnosis of atypical squamous cells of undetermined significance is influenced by patient history and type of follow-up.
Diagnostic cytopathology 1997;17(1):14-9.
1997: David L Rimm; JF Stastny; EB Rimm; S Ayer; William J Frable
Comparison of the costs of fine-needle aspiration and open surgical biopsy as methods for obtaining a pathologic diagnosis.
Cancer 1997;81(1):51-6.
1995: W E Pierceall; Amy S Woodard; Jon S Morrow; David L Rimm; Eric R Fearon
Frequent alterations in E-cadherin and alpha- and beta-catenin expression in human breast cancer cell lines.
Oncogene 1995;11(7):1319-26.
1995: David L Rimm; E R Koslov; P Kebriaei; Carol D Cianci; Jon S Morrow
Alpha 1(E)-catenin is an actin-binding and -bundling protein mediating the attachment of F-actin to the membrane adhesion complex.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(19):8813-7.
1995: David L Rimm; John H Sinard; Jon S Morrow
Reduced alpha-catenin and E-cadherin expression in breast cancer.
Laboratory investigation; a journal of technical methods and pathology 1995;72(5):506-12.
1995: David L Rimm; T E Holland; Jon S Morrow; James M Anderson
Autoantibodies specific for villin found in patients with colon cancer and other colitides.
Digestive diseases and sciences 1995;40(2):389-95.
1994: David L Rimm; P Kebriaei; Jon S Morrow
Molecular cloning reveals alternative splice forms of human alpha(E)-catenin.
Biochemical and biophysical research communications 1994;203(3):1691-9.
1994: David L Rimm; Jon S Morrow
Molecular cloning of human E-cadherin suggests a novel subdivision of the cadherin superfamily.
Biochemical and biophysical research communications 1994;200(3):1754-61.
1991: Vijay M Thadani; David L Rimm; L Urquhart; L Fisher; Peter D Williamson; R Enriquez; Jung H Kim; L L Levy
'Locked-in syndrome' for 27 years following a viral illness: clinical and pathologic findings.
Neurology 1991;41(4):498-500.
1991: Thomas D Pollard; David L Rimm
Analysis of cDNA clones for Acanthamoeba profilin-I and profilin-II shows end to end homology with vertebrate profilins and a small family of profilin genes.
Cell motility and the cytoskeleton 1991;20(2):169-77.
1990: John H Sinard; David L Rimm; Thomas D Pollard
Identification of functional regions on the tail of Acanthamoeba myosin-II using recombinant fusion proteins. II. Assembly properties of tails with NH2- and COOH-terminal deletions.
The Journal of cell biology 1990;111(6 Pt 1):2417-26.
1990: David L Rimm; Don Kaiser; D Bhandari; P Maupin; D P Kiehart; Thomas D Pollard
Identification of functional regions on the tail of Acanthamoeba myosin-II using recombinant fusion proteins. I. High resolution epitope mapping and characterization of monoclonal antibody binding sites.
The Journal of cell biology 1990;111(6 Pt 1):2405-16.
1989: David L Rimm; Thomas D Pollard
Purification and characterization of an Acanthamoeba nuclear actin-binding protein.
The Journal of cell biology 1989;109(2):585-91.
1989: David L Rimm; John H Sinard; Thomas D Pollard
Location of the head-tail junction of myosin.
The Journal of cell biology 1989;108(5):1783-9.
1989: David L Rimm; Thomas D Pollard
New plasmid vectors for high level synthesis of eukaryotic fusion proteins in Escherichia coli.
Gene 1989;75(2):323-7.
1988: David L Rimm; Thomas D Pollard; P Hieter
Resolution of Acanthamoeba castellanii chromosomes by pulsed field gel electrophoresis and construction of the initial linkage map.
Chromosoma 1988;97(3):219-23.